97 related articles for article (PubMed ID: 5942994)
1. The crystal structures of compounds with antitumor activity. 2-keto-3-ethoxybutyraldehyde bis(thiosemicarbazone) and its cupric complex.
Taylor MR; Gabe EJ; Glusker JP; Minkin JA; Patterson AL
J Am Chem Soc; 1966 Apr; 88(8):1845-6. PubMed ID: 5942994
[No Abstract] [Full Text] [Related]
2. THE ANTI-TUMOR ACTIVITY OF 2-KETO-3-ETHOXYBUTYRALDEHYDE BIS(THIOSEMICARBAZONE) AND RELATED COMPOUNDS.
PETERING HG; BUSKIRK HH; UNDERWOOD GE
Cancer Res; 1964 Apr; 24():367-72. PubMed ID: 14147809
[No Abstract] [Full Text] [Related]
3. [The cytokinetic effect of 2-keto-3-ethoxybutyraldehyde bis-thiosemicarbazone on W256 cell].
Luo HY
Yao Xue Xue Bao; 1984 Apr; 19(4):296-9. PubMed ID: 6238505
[No Abstract] [Full Text] [Related]
4. Studies on the mode of action of the copper(II)chelate of 2-keto-3-ethoxybutyraldehyde-bis(thiosemicarbazone).
Bhuyan BK; Betz T
Cancer Res; 1968 Apr; 28(4):758-63. PubMed ID: 5649064
[No Abstract] [Full Text] [Related]
5. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
6. Identification of differential anti-neoplastic activity of copper bis(thiosemicarbazones) that is mediated by intracellular reactive oxygen species generation and lysosomal membrane permeabilization.
Stefani C; Al-Eisawi Z; Jansson PJ; Kalinowski DS; Richardson DR
J Inorg Biochem; 2015 Nov; 152():20-37. PubMed ID: 26335599
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and structure-activity relationships of four alpha-N-heterocyclic thiosemicarbazone derivatives crystal structure of 2-acetylpyrazine thiosemicarbazone.
Li MX; Chen CL; Ling CS; Zhou J; Ji BS; Wu YJ; Niu JY
Bioorg Med Chem Lett; 2009 May; 19(10):2704-6. PubMed ID: 19369075
[TBL] [Abstract][Full Text] [Related]
8. Copper(II) and cobalt(III) pyridoxal thiosemicarbazone complexes with nitroprusside as counterion: syntheses, electronic properties, and antileukemic activity.
Belicchi-Ferrari M; Bisceglie F; Casoli C; Durot S; Morgenstern-Badarau I; Pelosi G; Pilotti E; Pinelli S; Tarasconi P
J Med Chem; 2005 Mar; 48(5):1671-5. PubMed ID: 15743209
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and biological activities of semicarbazones and their copper complexes.
Venkatachalam TK; Bernhardt PV; Noble CJ; Fletcher N; Pierens GK; Thurecht KJ; Reutens DC
J Inorg Biochem; 2016 Sep; 162():295-308. PubMed ID: 27138101
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic activity, albumin and DNA binding of new copper(II) complexes with chalcone-derived thiosemicarbazones.
Da Silva JG; Recio Despaigne AA; Louro SR; Bandeira CC; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2013 Jul; 65():415-26. PubMed ID: 23747809
[TBL] [Abstract][Full Text] [Related]
11. Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effect.
Quach P; Gutierrez E; Basha MT; Kalinowski DS; Sharpe PC; Lovejoy DB; Bernhardt PV; Jansson PJ; Richardson DR
Mol Pharmacol; 2012 Jul; 82(1):105-14. PubMed ID: 22508546
[TBL] [Abstract][Full Text] [Related]
12. The antitumor activity of Cu(II)KTS, the copper (II) chelate of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
Crim JA; Petering HG
Cancer Res; 1967 Jul; 27(7):1278-85. PubMed ID: 4952520
[No Abstract] [Full Text] [Related]
13. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Lim JK; Mathias CJ; Green MA
J Med Chem; 1997 Jan; 40(1):132-6. PubMed ID: 9016338
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic characterization, antioxidant and antitumour studies of novel bromo substituted thiosemicarbazone and its copper(II), nickel(II) and palladium(II) complexes.
Jagadeesh M; Lavanya M; Kalangi SK; Sarala Y; Ramachandraiah C; Varada Reddy A
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():180-4. PubMed ID: 25064500
[TBL] [Abstract][Full Text] [Related]
15. Mn(II), Co(II) and Zn(II) complexes with heterocyclic substituted thiosemicarbazones: synthesis, characterization, X-ray crystal structures and antitumor comparison.
Li MX; Chen CL; Zhang D; Niu JY; Ji BS
Eur J Med Chem; 2010 Jul; 45(7):3169-77. PubMed ID: 20434816
[TBL] [Abstract][Full Text] [Related]
16. L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity.
Milunovic MN; Enyedy É; Nagy NV; Kiss T; Trondl R; Jakupec MA; Keppler BK; Krachler R; Novitchi G; Arion VB
Inorg Chem; 2012 Sep; 51(17):9309-21. PubMed ID: 22889304
[TBL] [Abstract][Full Text] [Related]
17. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone).
Petering HG; Buskirk HH; Crim JA
Cancer Res; 1967 Jun; 27(6):1115-21. PubMed ID: 6027202
[No Abstract] [Full Text] [Related]
18. Calcium release induced by 2-pyridinecarboxaldehyde thiosemicarbazone and its copper complex contributes to tumor cell death.
Fu Y; Liu Y; Wang J; Li C; Zhou S; Yang Y; Zhou P; Lu C; Li C
Oncol Rep; 2017 Mar; 37(3):1662-1670. PubMed ID: 28112358
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).
Sartorelli AC; Booth BA
Cancer Res; 1967 Sep; 27(9):1614-9. PubMed ID: 6051275
[No Abstract] [Full Text] [Related]
20. Palladium and platinum 3,5-diacetyl-1,2,4-triazol bis(thiosemicarbazones): chemistry, cytotoxic activity and structure-activity relationships.
Matesanz AI; Souza P
J Inorg Biochem; 2007 Feb; 101(2):245-53. PubMed ID: 17097146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
